Showing 9161-9170 of 21415 results for "".
Measuring IgAN Risk: Genetic, Environmental, and Systemic Factors
https://reachmd.com/programs/clinicians-roundtable/measuring-igan-risk-genetic-environmental-and-systemic-factors/29742/Learn about common risk factors for IgA nephropathy.Deciphering IgA Nephropathy: Insights into the Diagnostic Process
https://reachmd.com/programs/frontlines-iga-nephropathy/deciphering-iga-nephropathy-insights-into-the-diagnostic-process/26946/When IgA nephropathy is suspected, it’s important to follow a stepwise pattern to confirm those suspicions. Here’s what the diagnostic process looks like.Applying the 2024 McDonald Criteria: Real-World Impacts on MS Diagnosis
https://reachmd.com/programs/neurofrontiers/mcdonald-criteria-impacts-ms-diagnosis/56634/Early real-world experience with the 2024 McDonald criteria suggests a meaningful increase in multiple sclerosis (MS) diagnoses, driven largely by recognition of optic nerve involvement and reclassification of radiologically isolated syndrome. Hear from Dr. Aaron Miller as he reviews emergingAI and Hair Loss: Measuring Progress with Data-Driven Insights
https://reachmd.com/programs/clinicians-roundtable/ai-and-hair-loss-measuring-progress-with-data-driven-insights/32933/Explore how devices powered by artificial intelligence can impact the way dermatologists track hair loss through precise data.Next-Gen Clinical Monitoring: Predicting Inpatient Decline with AI-Driven Alerts
https://reachmd.com/programs/the-convergence/clinical-monitoring-inpatient-decline-ai-alerts/39924/An artificial intelligence (AI)-driven clinical alert model has the potential to reshape inpatient care by detecting early signs of deterioration an average of 17 hours before adverse events occur. Dr. Brian McDonough sits down with Dr. Theodoros Zanos, to learn more about how his team combined contThe Role of Neuromodulators in Treating IBS
https://reachmd.com/programs/gi-insights/the-role-of-neuromodulators-in-treating-ibs/28871/Here’s how neuromodulators can help provide symptom relief for patients with irritable bowel syndrome.Rethinking PH-ILD: What Emerging Data Could Mean for Patient Care
https://reachmd.com/programs/clinicians-roundtable/ph-ild-emerging-data-care/54228/What if pulmonary hypertension in interstitial lung disease (PH-ILD) is hiding in plain sight? Dr. Jean Elwing previews PH-ILD research taking center stage at CHEST 2026, exploring how familiar clinical clues could support earlier recognition and what emerging data may add to the evolving managementHelping Patients with IgAN Navigate Treatment Decisions
https://reachmd.com/programs/clinicians-roundtable/patients-treatment-decisions-igan/51007/Because patients with IgA nephropathy (IgAN) often have few symptoms early in the disease course, communicating the importance of treatment and its impacts on long-term outcomes can be challenging. Join Dr. Sayna Norouzi as she discusses practical communication techniques for explaining prognosis, sTargeting BAFF and APRIL in IgA Nephropathy
https://reachmd.com/programs/frontlines-iga-nephropathy/baff-april-iga-nephropathy/60616/Advances in our understanding of BAFF and APRIL biology are reshaping the treatment landscape for IgA nephropathy (IgAN), with dual pathway inhibition emerging as a promising disease-modifying strategy. Joining Dr. Gates Colbert for a conversation about the rationale, clinical potential, and remainiThe Inflammatory Drivers of Itch in Atopic Dermatitis
https://reachmd.com/programs/dermconsult/inflammatory-drivers-itch-atopic-dermatitis/60648/Itch is the defining symptom of atopic dermatitis and a major driver of patient burden and treatment satisfaction. Given that, Dr. Brian Kim joins us to examine the inflammatory mechanisms underlying itch, highlighting the roles of cytokines such as IL-4, IL-13, and IL-31 in activating sensory neuro